Dr. Bruce Elliot Gelb, MD

Dr. Gelb practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Gelb's NPI, 1780861054, was assigned on January 29, 2008. Dr. Gelb graduated from University of Texas Medical School at San Antonio in 2003. Dr. Gelb holds New York license 242945.

Dr. Gelb's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Gelb's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Gelb is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Dr. Gelb to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gelb practices, 2 sites in all. Vendor and product names are available with a free account.

Transplant surgery is Dr. Gelb's primary specialty in the NPI Registry, under taxonomy code 204F00000X. Dr. Gelb is licensed in New York.

CMS data shows 99 Medicare services from Dr. Gelb across 3 procedure codes in 2024, for 44 Medicare patients. Medicare paid $37,621 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 44 Medicare patients who saw Dr. Gelb in 2024. The largest group is under 65, with 20 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 39% are also on Medicaid. Their average risk score is 8.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gelb's median patient age at 62, with 30% women.

In 2018, Dr. Gelb wrote 407 Medicare Part D claims. They cover 16 drugs, with $29,040 in total drug cost. In 2017, CMS named 2,787 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Gelb for performance year 2024, reported as part of a group. Dr. Gelb accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 31 papers to Dr. Gelb, published from 2016 to 2025. 2020 was the busiest year, with 4. The most frequent topics are Facial Transplantation, Vascularized Composite Allotransplantation and Graft Rejection. Dr. Gelb has published most often in Plast Reconstr Surg. Dr. Gelb's most frequent co-authors are Rami Kantar, MD, MPHD, Adam Jacoby, MD and Bonnie Elizabeth Lonze, MD, PhD.

CMS Open Payments shows 37 general payments to Dr. Gelb from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 38% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $4,525.

Dr. Gelb graduated from University of Texas Medical School at San Antonio in 2003.